zomepirac has been researched along with Coronary Thrombosis in 1 studies
zomepirac: RN given refers to parent cpd; structure
Coronary Thrombosis: Coagulation of blood in any of the CORONARY VESSELS. The presence of a blood clot (THROMBUS) often leads to MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The antithrombotic activity of pelrinone, a phosphodiesterase III inhibitor was examined in a canine model of coronary thrombosis that uses electrical current to injure the coronary endothelium." | 3.68 | Potentiation of phosphodiesterase inhibitor antithrombotic activity with alpha-2 adrenergic blockade. ( Colatsky, TJ; Kitzen, JM; McCallum, JD; Pirozzi, CT, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitzen, JM | 1 |
| McCallum, JD | 1 |
| Pirozzi, CT | 1 |
| Colatsky, TJ | 1 |
1 other study available for zomepirac and Coronary Thrombosis
| Article | Year |
|---|---|
Potentiation of phosphodiesterase inhibitor antithrombotic activity with alpha-2 adrenergic blockade.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Coronary Thrombosis; Dogs; Drug Synergi | 1991 |